Matches in Wikidata for { <http://www.wikidata.org/entity/Q83916193> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q83916193 description "article scientifique publié en 2011" @default.
- Q83916193 description "artículu científicu espublizáu n'abril de 2011" @default.
- Q83916193 description "scientific article published on 01 April 2011" @default.
- Q83916193 description "wetenschappelijk artikel" @default.
- Q83916193 description "наукова стаття, опублікована у квітні 2011" @default.
- Q83916193 name "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 name "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 type Item @default.
- Q83916193 label "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 label "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 prefLabel "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 prefLabel "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 P1433 Q83916193-72B50341-8294-470E-B650-09D05121A8D7 @default.
- Q83916193 P1476 Q83916193-3600EA58-38D1-4ABC-9B55-20C1BEBFF618 @default.
- Q83916193 P2093 Q83916193-0D0F6B0B-45DC-4DDA-B054-D5085B314864 @default.
- Q83916193 P2093 Q83916193-49C29F27-D6F0-469F-B783-5A280C3FC2E8 @default.
- Q83916193 P2093 Q83916193-72997EB1-186C-40E7-BFD1-86FB5E8332C8 @default.
- Q83916193 P2093 Q83916193-B6FEC843-E8D4-49A0-8E65-0100D1D78C9E @default.
- Q83916193 P2093 Q83916193-EA7C7705-B0FB-4F29-9BBB-EABC1A665982 @default.
- Q83916193 P2093 Q83916193-F58D97FD-177E-4750-810B-36350A6DCC88 @default.
- Q83916193 P2093 Q83916193-FD7F7D7E-E92E-4B52-892F-BA70713FF9F0 @default.
- Q83916193 P304 Q83916193-3E4BB245-3D10-4BF0-945F-B5B92CEF91FF @default.
- Q83916193 P31 Q83916193-914B67DD-2239-4B80-B1DE-98A59E4DD1BA @default.
- Q83916193 P433 Q83916193-BEC353DB-CC1B-488F-B3DF-25A222426B40 @default.
- Q83916193 P478 Q83916193-7B457517-9DD7-4124-9CCF-C530264E03E1 @default.
- Q83916193 P50 Q83916193-C8BE96CF-0400-4DC4-81F1-5AF503605843 @default.
- Q83916193 P577 Q83916193-20B58241-A375-49B9-925C-6707DC9AA155 @default.
- Q83916193 P698 Q83916193-59943DA4-B760-4CF4-8733-2AAFE8AFBE01 @default.
- Q83916193 P921 Q83916193-9FA10EFE-50BE-4BCA-8022-E07EADFEC464 @default.
- Q83916193 P698 21508395 @default.
- Q83916193 P1433 Q326290 @default.
- Q83916193 P1476 "Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer" @default.
- Q83916193 P2093 "Charles Bradley" @default.
- Q83916193 P2093 "David R Fogelman" @default.
- Q83916193 P2093 "Fernando Cabanillas" @default.
- Q83916193 P2093 "Isabel Mok" @default.
- Q83916193 P2093 "Milind Javle" @default.
- Q83916193 P2093 "Robert A Wolff" @default.
- Q83916193 P2093 "Scott Kopetz" @default.
- Q83916193 P304 "1417-1420" @default.
- Q83916193 P31 Q13442814 @default.
- Q83916193 P433 "4" @default.
- Q83916193 P478 "31" @default.
- Q83916193 P50 Q14947937 @default.
- Q83916193 P577 "2011-04-01T00:00:00Z" @default.
- Q83916193 P698 "21508395" @default.
- Q83916193 P921 Q212961 @default.